Logo

People in the News: Steve Pemberton, Bryan Greene, Mark McDonough, Richard Hockett, Judd Jessup

Mar 13, 2013
Premium

Rheonix has named Steven Pemberton as its vice president of sales and marketing and Bryan Greene as its director of consumable manufacturing.

Pemberton formerly held leadership posts at Abbott Diagnostics, Ventana Medical Systems, and Roche Diagnostics while Greene previously was responsible for design transfer and product manufacturing at Life Technologies.

Ithaca, NY-based Rheonix markets its Hi-Fi SNP microarray platform for biomarker discovery and test development (BAN 12/20/2011).

CombiMatrix has elected its Chief Commercial Officer Mark McDonough and its Chief Medical Officer Richard Hockett to serve on its board of directors.

McDonough, who joined CombiMatrix last August from Pathwork Diagnostics, will take over as CEO later this week when current CEO Judd Jessup retires.

Filed under

Microarrays & Multiplexing
Rheonix
microarrays
Invitae
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.